BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Allergan Inc. 

2525 Dupont Drive

Irvine  California  92612  U.S.A.
Phone: 714-246-4500 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight


Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 11,100 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. For the year ending 2012, our total product net sales totaled $5.5 billion, a 10 percent increase over 2011. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than six decades of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to: www.allergan.com.


 Key Statistics


Email: Corpinfo@allergan.com
Ownership:

Web Site: Allergan Inc.
Employees: 11,100
Symbol: AGN
 



Industry
Pharmaceutical


Collaborations

Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

ACADIA Pharmaceuticals, Inc.  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

ACADIA Pharmaceuticals, Inc.  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

ACADIA Pharmaceuticals, Inc.  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.





 Company News
Allergan Inc. (AGN) To Hold Special Meeting Of Stockholders On Originally Scheduled Date Of December 18 Without Restriction 9/16/2014 12:59:07 PM
Pershing Square, Valeant Pharmaceuticals International (VRX) And Allergan Inc. (AGN) Settle Pending Litigation Before The Delaware Court Of Chancery 9/16/2014 8:43:37 AM
Allergan Inc. (AGN) To Slash 129 California Jobs Amid Hostile Takeover Battle 9/15/2014 7:02:12 AM
More Than 35% Of Allergan Inc. (AGN) Investors Demand Special Meeting; Support For Valeant Pharmaceuticals International (VRX) Merger Grows 9/12/2014 6:50:13 AM
Jazz Pharmaceuticals plc (JAZZ) Stock Up On Allergan Inc. (AGN) Rumor 9/8/2014 11:04:55 AM
Allergan Inc. (AGN) Provides Update On Written Requests From Pershing Square Regarding Special Meeting Of Stockholders 9/5/2014 12:07:05 PM
Allergan Inc. (AGN) Files Answer In Federal Court Responding To Valeant Pharmaceuticals International (VRX) And Pershing Square’s Counterclaims 9/2/2014 12:35:35 PM
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema 9/2/2014 11:16:42 AM
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014 9:51:47 AM
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014 6:08:18 AM
12345678910...